Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 3/20 | 0.53 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.50 |
| ▸ | SCN9A | Q15858 | 4/20 | 0.50 |
| ▸ | SCN5A | Q14524 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.46 |
| ▸ | DRD2 | P14416 | 4/20 | 0.43 |
| ▸ | DRD4 | P21917 | 3/20 | 0.43 |
| ▸ | AR | P10275 | 2/20 | 0.43 |
| ▸ | DRD3 | P35462 | 3/20 | 0.43 |
| ▸ | JAK1 | P23458 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7028629 | 1.00 | MTNR1A (0.53) | MTNR1AMTNR1BKCNH2SCN9ASCN5A | |
| SCHEMBL7030412 | 0.90 | MTNR1A (0.54) | MTNR1AMTNR1BKCNH2SCN9ASCN5A | |
| SCHEMBL7030407 | 0.90 | MTNR1A (0.54) | MTNR1AMTNR1BKCNH2SCN9ASCN5A | |
| SCHEMBL7027929 | 0.90 | MTNR1A (0.65) | MTNR1AMTNR1BKCNH2SCN9ASCN5A | |
| SCHEMBL7027930 | 0.90 | MTNR1A (0.65) | MTNR1AMTNR1BKCNH2SCN9ASCN5A | |
| SCHEMBL7023472 | 0.89 | MTNR1A (0.55) | MTNR1AMTNR1BKCNH2SCN9ASCN5A | |
| SCHEMBL7026020 | 0.89 | MTNR1A (0.53) | MTNR1AMTNR1BKCNH2SCN9ASCN5A | |
| SCHEMBL7030289 | 0.89 | MTNR1A (0.55) | MTNR1AMTNR1BKCNH2SCN9ASCN5A | |
| SCHEMBL7026015 | 0.89 | MTNR1A (0.53) | MTNR1AMTNR1BKCNH2SCN9ASCN5A | |
| SCHEMBL7031005 | 0.88 | MTNR1A (0.57) | MTNR1AMTNR1BKCNH2SCN9ASCN5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888319-B1 | SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES | ASTRAZENECA AB (SE) | 2003-01-29 | — | — | EP | disclosed |
| US-6410530-B1 | CENTRAL NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS | ASTRAZENECA AB (SE) | 2002-06-25 | — | — | US | disclosed |
| US-6124283-A | Substituted 1,2,3,4-tetrahydronaphthalene derivatives | ASTRA AKTIEBOLAG (SE) | 2000-09-26 | — | — | US | disclosed |
| EP-0888319-A1 | SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES | Astra Aktiebolag (SE) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997034883-A1 | SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES | ASTRA AKTIEBOLAG (SE) | 1997-09-25 | — | — | WO | disclosed |